George Robinson

Sloane Robinson LLP is the alternative investment management subsidiary of Sloane Robinson Investment Services Ltd. in Great Britain. The firm was founded by Hugh Sloane and George Robinson in 1993 as Sloane Robinson Investment Management Ltd. They changed their name to Sloane Robinson Investment Partners LLP in 2004. Headquartered in London, Sloane Robinson manages assets with an absolute return focus on behalf of professional investors throughout the world.

John Swire & Sons (H.K.) Ltd. is an investment holding company. The company was founded on October 30, 1947 and is headquartered in Hong Kong.

Oxford Photovoltaics Ltd. develops and commercialize perovskite-based technology. Its technology can be coated on architectural glass to allow large buildings to generate a significant proportion of their electricity demand, effectively turning them into vertical solar farms. The firm investors include MTI partners, Longwall Venture Partners LLP, Parkwalk, University of Oxford (OSEM). The company was founded by Kevin Arthur and Henry Snaith in December 2010 and is headquartered in Kidlington, the United Kingdom.

Sloane Robinson Investment Services Ltd. is a British equity asset management company founded in 1993. The private company is based in London, UK, and has subsidiaries in the United Kingdom, United States, Mauritius, and Cayman Islands. The company primarily focuses on international equity markets, with an emphasis on Asian and emerging markets. For further information, please contact info@sloanerobinson.com.

Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom.

The Maggie Keswick Jencks Cancer Caring Centres Trust provides free practical, emotional, and social support services to people with cancer. The non-profit company is based in Edinburgh, UK. The British company was founded in 1996 by Maggie Keswick Jencks and Charles Jencks. Dame Laura Lee has been the CEO of the company since 1998.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London.